Skip to main content
See every side of every news story
Published • loading... • Updated

Strain-Specific Ebola Jab Trials to Start in DR Congo Next Week: WHO

Summary by Anadolu Ajansı
Vaccines by Oxford University-Serum Institute of India, Moderna, approved to advance to phase 2 trials, with more than 140 participants enrolled in broader trial

3 Articles

Lean Right

Vaccines by Oxford University-Serum Institute of India, Moderna, approved to advance to phase 2 trials, with more than 140 participants enrolled in broader trial

·Ankara, Türkiye
Read Full Article

Declared in the Democratic Republic of the Congo in May this year, the 17th Ebola epidemic is already the deadliest in the country's history. Next week, two vaccine-candidates enter clinical trials, the World Health Organization announced this Tuesday.

·Lisboa, Portugal
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

RTP broke the news in Lisboa, Portugal on Tuesday, November 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal